Niromed’s Post

The increasing length of time we're seeing for drug shortages really highlights the fragility of our healthcare supply chains, which is easily exacerbated by economic pressures and complex manufacturing processes. If this trend continues (and I fear it will), we're going to face significant challenges in ensuring timely access to essential medications, potentially compromising patient care and public health outcomes. There are no clear solutions, but I imagine production incentivization and supply chain diversification could be among the most effective tangible solutions. What potential fixes could you see? #DrugShortages #SupplyChain #Healthcare

Regulations in countries like China and India are emphasizing food and drug safety, promoting the development of cold chain markets crucial for ensuring the integrity of medical supplies. Additionally, the rise of telehealth and remote patient monitoring is increasing the demand for logistics services that can support new care delivery models. At Globyz Biopharma, we not only ensure that healthcare products are safely delivered but also focus on enhancing accessibility worldwide through our comprehensive logistics services. From clinical trials supply management to advanced cold chain storage solutions, we are committed to supporting the dynamic needs of the healthcare industry. Explore how our global distribution network and innovative services can support your healthcare logistics needs at www.globyz.com or reach out to us at info@globyz.com. #HealthcareLogistics #GlobyzBiopharma #ColdChainLogistics #Telehealth #RemotePatientMonitoring #GlobalHealth

In our latest survey, the persistent issue of drug shortages has been highlighted, revealing significant impacts on patient care and rising costs. You can download your own FREE copy here 👉 https://lnkd.in/eBJakn8J Supply chain leaders shared their experiences, underscoring the struggles they face: 🔹 Patient care delays 🔹 Rising drug prices 🔹 Increased reliance on alternative medicines These challenges are not just numbers—they represent real hurdles in providing timely and effective care. However, amidst this turbulence, there is hope. Supply chain leaders are recognising the urgency of the situation. By focusing on innovation and strategic adjustments, we can navigate through these shortages and improve patient outcomes. The path ahead may be challenging, but with dedicated efforts, there is light at the tunnel's end. Let's continue to support these crucial transformations in our supply chains to ensure better healthcare for all. 💪💊 #Supplychain #PharmaInsights #Insights

In our latest survey, the persistent issue of drug shortages has been highlighted, revealing significant impacts on patient care and rising costs. You can download your own FREE copy here 👉 https://lnkd.in/eBJakn8J Supply chain leaders shared their experiences, underscoring the struggles they face: 🔹 Patient care delays 🔹 Rising drug prices 🔹 Increased reliance on alternative medicines These challenges are not just numbers—they represent real hurdles in providing timely and effective care. However, amidst this turbulence, there is hope. Supply chain leaders are recognising the urgency of the situation. By focusing on innovation and strategic adjustments, we can navigate through these shortages and improve patient outcomes. The path ahead may be challenging, but with dedicated efforts, there is light at the tunnel's end. Let's continue to support these crucial transformations in our supply chains to ensure better healthcare for all. 💪💊 #Supplychain #PharmaInsights #Insights

🚩 Drug Shortages: A Critical Threat to Patient Care and the Economy ✍️ The increasing frequency and severity of drug shortages pose a significant challenge to healthcare systems worldwide. 📌 From impacting patient safety and treatment outcomes to disrupting the economy, this crisis demands immediate attention and collaborative action. ✨️ Pharmacists are on the frontlines of this issue, working tirelessly to find alternatives, educate patients, and ensure continuity of care. 🔆 However, addressing drug shortages requires a multi-faceted approach involving health authorities, pharmacists, physicians, and government. ✳️ Key challenges include: 🟢Disruptions in patient care and treatment adherence 🟢Increased healthcare costs due to medication substitutions and alternative therapies 🟢Economic burden on patients, healthcare providers, and the overall economy 🟧 Potential solutions: 🟠 Strengthening the drug supply chain through diversification and risk management 🟠Promoting generic drug utilization and interchangeability 🟠Enhancing real-time data sharing and early warning systems 🟠Investing in domestic drug manufacturing capabilities ✅️ It's imperative that we work together to develop comprehensive strategies to mitigate the impact of drug shortages. 🏁 By fostering collaboration and sharing expertise, we can build a more resilient healthcare system that prioritizes patient safety and well-being. #drugshortages #pharmacist #healthcare #patientcare #supplychain #economy #collaboration #healthpolicy

Shed Light on China’s Integrated Health Management System Policy Evolution and Challenges China's Integrated Health Management System (IHMS) is crucial for advancing its healthcare reform. However, there is a lack of comprehensive analysis on IHMS policies, hindering its development. A study analyzed 152 policy documents using the PRISMA guidelines and a 6D framework. Findings revealed an imbalance in internal policy tools and the need to improve physician and resident participation. Regional differences were observed, with Shanghai leading in healthy initiatives. The study also identified an evolutionary trend in policy tools from 2014-2021. Adjustments, such as coordinating policy tools and stakeholder relationships, focusing on local characteristics, and integrating health resources at the community level, are recommended. The study provides a framework for future policy formulation and optimization. For more details please click the link! https://lnkd.in/dhEiBUiX #marketaccess #reimbursement #pricing #hta #heor #healtheconomics #medicaldevices #pharmaceutical

Bridging the #Gap Between #Quality and #Affordability Is it possible to maintain high medicine quality standards while ensuring affordability? The answer is #YES. 🏭 High Scale Economy Production At EVA pharma, we leverage #Economies_Of_Scale by manufacturing over 1 million packs of medicines daily. This ensures our medicines remain #Affordable and sustainably #Accessible to patients in need. 💊 #World_Class Globally #Accredited #Facilities Our #state_of_the_art facilities adhere to the highest standards and are accredited by #European_Medicine_Agencies, #Health_Canada, and other reputable bodies. This ensures that every product we manufacture exceeds global #Quality_Standards and is accessible to patients in over 40 countries across Europe, Canada, Africa, and beyond. At EVA Pharma, we believe that #Health and #Wellbeing is a #HumanRight that we empower every day. #EVAPharma #GlobalQuality #Healthcare #PharmaceuticalInnovation

After years of delays, new drug price transparency requirements may be on the horizon. In a new Insight, #AvalereExpert Kolton Gustafson, MPH details the history of recent transparency initiatives and what stakeholders need to know about the increased availability of information related to negotiated prices on drugs and other services: https://lnkd.in/egNM8_rS #drugpricing #pricingtransparency #lifesciences #lifesciencesindustry #healthpolicy #healthcare #IRA #InflationReductionAct

What Opportunities Exist in #AdvancedDrug \Delivery Solutions? The rise in #chronicdiseases and #healthcare expenditure, coupled with increased consumer awareness and government initiatives, creates significant opportunities for R&D in advanced drug delivery. Investing in solutions for better drug efficacy and safety enhances market growth. Want To Know More:https://lnkd.in/d-BSDB9P #AMR #DrugDeliveryMarket #ChronicDiseases #HealthcareExpenditure #RandDInvestments #MarketGrowth #AdvancedTherapeutics